Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study - Wikidata - awgldk - TriplyDB

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

http://www.wikidata.org/entity/Q35826703

about

Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature Influence of Pharmacotherapy on Cognitive Functions in Depression: A Review of the Literature Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study Isoflurane-induced spatial memory impairment in mice is prevented by the acetylcholinesterase inhibitor donepezil Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium.Delirium in early-stage alzheimer's disease: enhancing cognitive reserve as a possible preventive measure.Turning over the rocks: role of anticholinergics and benzodiazepines in cognitive decline and falls.Potentially inappropriate medication use in older adults with mild cognitive impairment.Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients.Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.Cognitive decline in older persons initiating anticholinergic medications.Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients.The Influence of Patient Characteristics on Anticholinergic Events in Older People.Overactive bladder syndrome in older people.Neurocognitive costs and benefits of psychotropic medications in older adults.The cognitive impact of anticholinergics: a clinical review.Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults Exploration of 100 commonly used drugs and supplements on cognition in older adults Drug Burden Index and physical function in older Australian men.Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study.Over-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults.Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review.Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.Anticholinergics: theoretical and clinical overview.Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.Trends in Medication Use Over 11 Years in Patients Presenting to a Rural and Remote Memory Clinic.Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database.Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.Treating older people.Antioxidant, Acetylcholinesterase, Butyrylcholinesterase, and α-glucosidase Inhibitory Activities of Corchorus depressus.Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.

P2860

Q26752928-787E7A16-5EF2-43E3-898E-3EAE2A3224ED Q27694555-83A9EEA5-48C8-4E5E-8546-8938614BA9B7 Q28085414-16F8D92E-155D-46B2-8E87-8612C7CE7472 Q28255929-F192533C-8894-49EB-A77A-716E8EC57AE8 Q28478062-76879609-0B53-47EE-AE3B-4DC2A7093275 Q30559371-A34E91C3-EA7A-46B5-B4A3-0168EAC0BA8E Q33369568-2F1FDEF3-E287-4429-8310-7147C3FD8131 Q33622899-EEF458AA-3404-4927-9443-59360DC10F6F Q33715169-CE14D782-1607-4F65-8787-73F54FDE32DA Q33997305-53B8B2F1-4736-49B8-BAF2-179ACEF5ECC6 Q34016202-00443DD9-1AF0-469E-91B0-EC218A32BD37 Q34104256-FB469099-681B-4DF4-BFC3-CE7749AC1589 Q34760402-B2090E2F-07DF-40EC-A14F-165157EA2970 Q35162941-86EA2067-9D7B-471B-A904-0A8F509AE5DD Q35944999-99A235BC-705F-4623-BBCA-4CF03A245357 Q36277027-0C6FA812-D757-436C-AAB5-61F8B60A0A09 Q36650690-3CA24E41-D7F3-47AB-8068-A4DEC9EE2DD4 Q36779724-846993DB-A26D-4683-8B45-2CA7996E2B29 Q37001163-E698F1BE-22BF-4923-9CD9-32E33A6E6E71 Q37230472-3A6CEB03-88A7-4135-96C3-E110549374C0 Q37268405-FD46289C-D93C-4150-9DF8-1B37DCCF0408 Q37297346-9B14D4AC-F213-40D2-A002-8F2C6A5CF74F Q37321432-53FDC4C6-DFB1-4DF1-BEB5-F406649A0C5A Q37347897-C0211489-84F1-4849-918A-1E60F3BBA4E8 Q37446075-2CC2C6F8-FE68-4725-B62E-2267C840B5C7 Q37529854-44368926-DE4A-4F52-BED0-A252D09295F0 Q37634389-B15D64AD-89CA-44A1-9B76-BAA355F764D9 Q38027567-A10CDF22-982F-42D7-90CE-4A3EEC3D3486 Q38187907-39FD25A6-5A80-4FEB-A279-934BE242B952 Q38452282-6C8AFA8D-1829-4A84-8300-0221F8F8FBE1 Q38457002-7BA49AF9-EED0-4199-94F9-1796247A1F13 Q38769800-9D2F1FB9-8551-4949-A4D3-FFF228185725 Q38886942-AD084973-F816-4592-BF00-D4C01D178DD6 Q39202610-7B4A957E-7AA8-4FA5-8255-097D77549780 Q39379518-29E6F83C-8E9C-4F49-A286-6DCA9D7F7386 Q39846163-3C41AE50-3CD2-4879-9E38-11628923C6AC Q41214474-20C29908-7FFB-4FD7-BD46-009CBD3BB693 Q43631044-CDFC5067-6FC5-4576-A8DB-3BBF0A213FEF Q45074641-AB4A94CC-5E09-4BC5-8F58-9A1BEF1F025F Q45129739-4E47BC75-A45A-4659-AC65-C8DC56757007

P2860

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

http://www.wikidata.org/entity/Q35826703

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Drugs with anticholinergic pro ...... results from the PAQUID Study

@ast

Drugs with anticholinergic pro ...... results from the PAQUID Study

@en

type

label

Drugs with anticholinergic pro ...... results from the PAQUID Study

@ast

Drugs with anticholinergic pro ...... results from the PAQUID Study

@en

prefLabel

Drugs with anticholinergic pro ...... results from the PAQUID Study

@ast

Drugs with anticholinergic pro ...... results from the PAQUID Study

@en

P1433

Q35826703-4700592C-D5D0-4691-9F3D-298090EAB58E

P1476

Q35826703-02917F49-1D15-4794-84DD-04BB384396A5

P2093

Q35826703-56BBCE92-8BF3-456D-B63F-415FC3076023

Q35826703-7ACAE419-1BBF-4248-9B92-988DA836431E

Q35826703-EE5CE2AF-3D59-4F3C-B387-F105169F0524

Q35826703-F243FEC3-4799-4E03-BC72-DEB7091777B2

P2860

Q35826703-07093728-0B70-4897-9859-D5DE234B37B8

Q35826703-0B31C316-3610-4A83-AE32-3C286E99CA89

Q35826703-0F859122-F9AF-4EF5-B923-E206C4E94EB9

Q35826703-109AC884-D871-4C84-9E2D-175847CF042C

Q35826703-1330BF88-CD04-493C-8976-7570DB065217

Q35826703-14E4BD09-C0B5-43EF-A8E7-72F4315403F1

Q35826703-1B7EF7D2-777B-480B-85E3-307A74A8F292

Q35826703-227CA918-CBF9-49CE-BB38-F6E23AF2A01D

Q35826703-43AF24D9-1F19-4F61-AD8E-9F95E64BE2C9

Q35826703-5B6DBE99-6321-4E3C-8AEE-1D21594B343A

P304

Q35826703-F738E263-31C6-427B-9497-B24B1AF557ED

P31

Q35826703-6A187F3E-70CC-46C2-8796-308D747D744F

P356

Q35826703-13002AE7-6E57-408F-B53D-B30369C7A2B4

P407

Q35826703-811A04AA-4A94-480A-B701-252D9637B275

P433

Q35826703-0B29F18B-8AB8-4282-90E7-C966FBAAFD18

P478

Q35826703-C24D0A22-06FC-44CA-96EF-08B37EF581F9

P50

Q35826703-5D06536C-1CBA-40D7-84D8-F12D66D1ACA5

P577

Q35826703-15DD1482-715D-4388-B479-A58601CD6F41

P5875

Q35826703-11B13ED6-E231-4A43-AA5F-1AF06BC2588C

P698

Q35826703-AAD2E45A-E577-46B5-9618-58B3F68806E5

P932

Q35826703-C8CC22F3-3528-443F-B58B-2C2C72BA03BD

P356

J.1365-2125.2004.02232.X

P1433

British Journal of Clinical Pharmacology

P1476

Drugs with anticholinergic pro ...... results from the PAQUID Study

@en

P2093

Annie Fourrier-Réglat

http://www.w3.org/2001/XMLSchema#string

Colette Fabrigoule

http://www.w3.org/2001/XMLSchema#string

Jean-François Dartigues

http://www.w3.org/2001/XMLSchema#string

Nathalie Lechevallier-Michel

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The cholinergic hypothesis of geriatric memory dysfunction

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Drug-induced cognitive impairment in the elderly.

Serum anticholinergic activity levels and delirium in the elderly.

Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients.

Explicit criteria for determining potentially inappropriate medication use by the elderly. An update.

Snipping the thread of life. Antimuscarinic side effects of medications in the elderly.

P304

143-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2004.02232.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Mathieu Molimard

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8056139

http://www.w3.org/2001/XMLSchema#string

P698

15676035

http://www.w3.org/2001/XMLSchema#string

P932

1884748

http://www.w3.org/2001/XMLSchema#string